Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ETR/FYB stock hub

ETR/FYB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/FYBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

332.3M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/FYB

In the news

Latest news · ETR/FYB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROE-15

P25 -6.7P50 8.5P75 17.2

ROIC-9.1

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/FYB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

EUR

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	245
Employees Change	-5%
Employees Change Percent	-2
Enterprise value	EUR 273M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	DE000A1EWVY8
Last refreshed	2026-05-10
Market cap	EUR 332.3M
Price	EUR 18.8
Price currency	EUR
Rev Per Employee	177,904x
Sector	Healthcare
Sic	2836
Symbol	etr/FYB
Website	https://www.formycon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.47%
EV Earnings	-4.22x
EV/FCF	27.17x
EV/Sales	6.14x
FCF yield	3.02%
P/B ratio	0.83x
P/S ratio	7.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-68.49%
EBITDA Margin	-10.83%
FCF margin	22.59%
Gross margin	8.04%
Gross Profit	EUR 3.6M
Gross Profit Growth	-75.89%
Gross Profit Growth Q	241.29%
Gross Profit Growth3 Y	-33.34%
Gross Profit Growth5 Y	-14.73%
Net Income	EUR -64.7M
Net Income Growth Years	1%
Pretax Margin	-203.47%
Profit Margin	-145.46%
Profit Per Employee	EUR -258,784
ROA	-2.52
Roa5y	-3.64
ROCE	-4.44
ROE	-15.03
Roe5y	-5.53
ROIC	-9.05
Roic5y	-12.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.95%
Cagr15y	5.75%
Cagr1y	-20.35%
Cagr3y	-36.05%
Cagr5y	-21.36%
EPS Growth Years	1
FCF Growth Q	-15.33%
OCF Growth Q	-18.54%
OCF Growth10 Y	35.5%
Revenue Growth	-36.17x
Revenue Growth Q	-12.59x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	1.53x
Revenue Growth5 Y	5.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.06
Assets	EUR 739.5M
Cash	EUR 68.8M
Current Assets	EUR 125M
Current Liabilities	EUR 53.6M
Debt	EUR 9.6M
Debt Equity	EUR 0.02
Debt FCF	EUR 0.95
Equity	EUR 399.1M
Interest Coverage	-9.76
Liabilities	EUR 340.4M
Long Term Assets	EUR 614.5M
Long Term Liabilities	EUR 286.8M
Net Cash	EUR 59.3M
Net Cash By Market Cap	EUR 17.84
Net Cash Growth	89.77%
Net Debt Equity	EUR -0.15
Net Debt FCF	EUR -5.9
Tangible Book Value	EUR -14.9M
Tangible Book Value Per Share	EUR -0.84
WACC	8.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.33
Inventory Turnover	35.32
Net Working Capital	EUR 4.1M
Quick ratio	1.89
Working Capital	EUR 71.5M
Working Capital Turnover	EUR 0.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-17.89%
1Y total return	-20.34%
200-day SMA	22.69
3Y total return	-73.85%
50-day SMA	18.99
50-day SMA vs 200-day SMA	50under200
5Y total return	-69.92%
All Time High	94.1
All Time High Change	-80.02%
All Time High Date	2023-01-09
All Time Low	1.75
All Time Low Change	974.29%
All Time Low Date	2012-09-20
ATR	0.93
Beta	0.65
Beta1y	1.45
Beta2y	1.06
Ch YTD	-26.56
High	19.06
High52	31.3
High52 Date	2025-07-28
High52ch	-39.94%
Low	18.32
Low52	15.8
Low52 Date	2026-03-23
Low52ch	18.99%
Ma50ch	-1.02%
Price vs 200-day SMA	-17.13%
RSI	51.35
RSI Monthly	32.98
RSI Weekly	39.85
Sharpe ratio	-0.34x
Sortino ratio	-0.39
Total Return	-1%
Tr YTD	-26.56
Tr15y	131.29%
Tr1m	5.86%
Tr1w	4.91%
Tr3m	-18.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -30.5M
Operating margin	-68.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,363,930%
Net Borrowing	57,460,000
Shares Insiders	14.23%
Shares Institutions	2.79%
Shares Out	17,672,927
Shares Yo Y	1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 8.2M
Average Volume	11,678.65x
Bv Per Share	22.58
CAPEX	EUR -737,000
Ch10y	-17.89
Ch15y	130.7
Ch1m	5.86
Ch1w	4.91
Ch1y	-20.34
Ch3m	-18.26
Ch3y	-73.85
Ch5y	-69.92
Ch6m	-2.59
Change	-3.39%
Change From Open	-1.36
Close	19.46
Days Gap	-2.06
Depreciation Amortization	25,646,000
Dollar Volume	176,212.4
Earnings Date	2026-05-28
EBIT	EUR -30.5M
EBITDA	EUR -4.8M
EPS	EUR -3.66
F Score	2
FCF	EUR 10M
FCF EV Yield	3.68x
FCF Per Share	EUR 0.57
Financing CF	53,684,000
Fiscal Year End	December
Founded	1,999
Income Tax	EUR -25.8M
Investing CF	-37,455,000
Is Primary Listing	1
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Ma150	22.01
Ma150ch	-14.56%
Ma20	18.48
Ma20ch	1.74%
Net CF	27,011,000
Next Earnings Date	2026-05-28
Open	19.06
P FCF Ratio	33.07
P OCF Ratio	30.81
Position In Range	64.86
Ppne	13,664,000
Price Date	2026-05-08
Relative Volume	0.82x
Revenue	44,476,000x
SBC By Revenue	4.08x
Share Based Comp	1,813,000
Tax By Revenue	-58.01x
Tr6m	-2.59%
Volume	9,373
Z Score	0.71

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/FYB pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/FYB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/FYB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.8%

Share of float held by funds and institutions

Insider ownership

+14.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.0%

Negative means the company is buying back shares.

Technical

ETR/FYB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.3

Neutral momentum band

Price vs 200-day MA

-17.1%

50/200-day relationship not available

Beta (5Y)

0.65

Less volatile than the market

Sharpe ratio

-0.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/FYB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/FYB stock rating?

etr/FYB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/FYB analysis?

The full report lives at /stocks/etr/FYB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/FYB?

The latest report frames etr/FYB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/FYB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.